RareCyte snags $22 mln

Seattle-based RareCyte Inc, a creator of liquid and tissue biopsy analysis platforms, has closed $22 million in financing.

Seattle-based RareCyte Inc, a creator of liquid and tissue biopsy analysis platforms, has closed $22 million in financing. HealthQuest Capital led the round.

Source: Press Release